AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 1 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $212 | +24.7% | 186 | 0.0% | 0.00% | – |
| Q2 2023 | $170 | +63.5% | 186 | 0.0% | 0.00% | – |
| Q1 2023 | $104 | -2.8% | 186 | 0.0% | 0.00% | – |
| Q4 2022 | $107 | – | 186 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 186 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 186 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 186 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 186 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 186 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | – | 186 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 186 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 186 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,642,000 | 3.05% |
| Orchard Capital Management, LLC | 251,826 | $89,000 | 0.03% |
| Bayesian Capital Management, LP | 304,100 | $107,000 | 0.02% |
| Icon Wealth Partners, LLC | 400,132 | $141,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,339,043 | $2,592,000 | 0.01% |
| Ergoteles LLC | 849,000 | $300,000 | 0.01% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| HRT FINANCIAL LP | 1,103,737 | $389,000 | 0.00% |
| Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 777,617 | $275,000 | 0.00% |